Constipation is a common clinical problem encountered in primary care settings, with a prevalence of up to 27% in North America. Despite its frequency, diagnosing and managing constipation can be a complex task due to its multifactorial etiology and the variety of treatment options available.
Constipation can be primarily due to slow colonic transit or disorders of defecation. The former is characterized by infrequent bowel movements, while the latter involves difficulty in evacuation. A thorough understanding of the underlying pathophysiology aids in devising an appropriate diagnostic and therapeutic approach.
Diagnosis primarily relies on the patient's symptoms, supplemented by physical examination and necessary investigations. Rome IV criteria, which includes infrequent bowel movements, straining, lumpy or hard stools, and a sense of incomplete evacuation, is a valuable tool for diagnosis. Investigations like colonoscopy or imaging studies may be required in select cases.
Management should be individualized, considering the patient's symptoms, underlying pathophysiology, and preferences. Lifestyle modifications, including increased dietary fiber and fluid intake, regular exercise, and timely defecation, form the cornerstone of management. Pharmacological interventions, like laxatives, are indicated when lifestyle modifications are insufficient. In refractory cases, biofeedback therapy or surgery may be considered.
Emerging evidence suggests beneficial roles of probiotics in managing constipation. Probiotics can modulate the gut microbiota, enhancing the gut motility and stool consistency. However, further research is needed to establish their routine use in clinical practice.
Constipation is a common but often challenging clinical problem. A comprehensive approach, understanding the underlying pathophysiology, utilizing appropriate diagnostic tools, and individualized management strategies, can effectively manage constipation. Emerging therapies like probiotics offer promising avenues for future research and treatment.
1.
Prostate cancer death risk is higher in late teens and early 20s weight gain.
2.
Bayer is transforming pharmaceutical research into women's health
3.
Biomarker panel offers hope for early pancreatic cancer detection
4.
A small rise in cancer was observed following the 1986 Chernobyl accident.
5.
Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC
1.
Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances
2.
Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology
3.
Immune Microenvironment Biomarkers for Early Tumor Evolution
4.
Transformative Methods in Oncology and Quality Improvement
5.
Unveiling the Mystery of Epstein-Barr Virus: What We Know So Far
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation